18 Feb
paro y contratos junio 2022

EP: Reprotoxic substances covered by binding maximum exposure levels for the first time

Yesterday (Thursday 18 February 2022), European Parliament gave the final green light for an update to EU rules on limiting workers’ exposure to carcinogens, mutagens or reprotoxic substances.

An informal agreement with EU governments, reached in December 2021, was adopted by MEPs, with 686 votes in favour, 4 against and 4 abstentions. The updated EU law aims at strengthening workers’ protection against carcinogenic and other hazardous substances, by setting EU-wide occupational exposure limits.

MEPs succeeded in including reprotoxic substances within the scope of the Directive for the first time. Reprotoxic substances are harmful to reproduction and can cause impaired fertility or infertility.

Parliament’s negotiators also secured an agreement that healthcare workers who deal with hazardous medicinal products (HMPs), half of which are reprotoxic, must receive sufficient and appropriate training on how to handle them safely.

Definition for HMPs

The agreed text asks the Commission to develop a definition for, and establish an indicative list of, HMPs, to and prepare guidelines for handling these substances, particularly in hospitals, by the end of 2022.

An estimated 12.7 million workers in Europe, of which 7.3 million are nurses, are potentially exposed to HMPs.

Acrylonitrile, nickel compounds, benzene and crystalline silica dust

The revised rules also provide for occupational exposure limits for acrylonitrile and nickel compounds, and revise the maximum limit for benzene downwards. In addition, the Commission has to present legislative proposals on occupational exposure limit values for 25 substances or groups of substance before the end of 2022.

The EU co-legislators call on the European Commission to launch, in 2022, a procedure to reduce the occupational exposure limits for crystalline silica dust, exposure to which causes particularly serious and disabling effects such as lung cancer and silicosis.

Next steps

Pending Council’s approval, the directive will enter into force on the twentieth day after its publication in the EU Official Journal. Member states will have two year to transpose the directive after its entering into force.


Call Us


We use cookies to improve your experience. If you continue, we consider that you accept the use of cookies